Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-08

Clinical Trial Update: Assessment of Paclitaxel-Induced Neuropathy

View source ↗

Summary

This clinical trial update concerns assessment of paclitaxel-induced neuropathy in cancer patients, including breast and ovarian cancer, and is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Chicago | Conditions: Cancer, Breast Cancer | Status: ACTIVE_NOT_RECRUITING